Navigation Links
Surprise! Better Sleep with Gene-Eden(R), an Antiviral Supplement
Date:8/10/2009

ROCHESTER, N.Y., Aug. 10 /PRNewswire/ -- Your sleeping problems might be caused by stress, depression, diet, or a disease such as Fibromyalgia (FM), and Chronic Fatigue Syndrome (CFS). But it can also be a result of a virus hiding in your body.

Recent studies show that chronic infection with viruses can cause sleep disorders. A recent scientific review written by Professor Mark Opp from the University of Michigan Medical School states that "Data reviewed demonstrate the extent to which sleep is altered during the course of (an) infection." In one of these studies, a team of scientists headed by Professor Jose G. Montoya from the University of Stanford School of Medicine showed that many people who suffer from a sleep disorder can benefit from an antiviral treatment. In this study a group of patients who had a high concentration of chronic viruses in their body and were suffering from sleep disturbances, were treated with the antiviral drug valganciclovir. The drug was highly successful. It resolved the sleep problems in 75% of the patients!

Gene-Eden(R): antiviral supplement for better sleep

The development of Gene-Eden was inspired by Dr. Hanan Polansky's discovery of the role of chronic viruses in chronic disease. To develop an effective supplement, the scientists at polyDNA scanned the scientific literature, read and analyzed thousands of papers, and identified natural ingredients which are effective against chronic viruses. The result is Gene-Eden(R), an antiviral supplement that targets viruses during their chronic infection phase, and as expected, is effective in getting better sleep.

For more information on Gene-Eden(R), and a chance for better sleep, visit http://www.gene-eden.com/sleep.htm

What about the sleeping pills like Ambien and supplements like melatonin?

According to the Consumer Reports website: "Most sleep drugs are supposed to be taken for no longer than two weeks or so, and continued use could lead to serious side effects or dependency; 'rebound' insomnia, in which sleeplessness returns and might actually worsen; memory lapses; and hallucinations."

What is the reason for these side effects? Sleeping pills like Ambien and supplements like melatonin change the chemistry in the brain and create an artificial chemistry more conducive to sleep. However, this artificial chemistry also produces the serious side effects, and because of the adoptive nature of the brain, the dreaded dependency.

Unlike these sleeping pills and supplements, Gene-Eden targets a common cause of the sleeping problems, chronic viruses in the body. Gene-Eden does not create an artificial chemistry, but recovers the more natural, healthy state characteristic of a system with little or no chronic viruses, a system that experiences uninterrupted, refreshing sleep.

For more information on Gene-Eden(R), and a chance for better sleep, visit http://www.gene-eden.com/sleep.htm

About:

The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a non-profit center with a mission to advance the research on the biology of chronic disease, and to accelerate the discovery of a cure for these diseases.

    Contact:

    Tal Davidson
    Phone: 585-200-5546
    Email: tdavidson@cbcd.net

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE The Center for the Biology of Chronic Disease
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Limb-sparing surgery may not provide better quality of life than amputation for bone cancer patients
2. Not-For-Profit Nursing Homes Fare Better in Studies
3. Tabyat Partners, LLC. Launches iluvmydoc.com™, to Better Connect Patients with Doctors
4. Freshly crushed garlic better for the heart than processed
5. For Some Kidney Patients, Home Dialysis Is Better
6. Look Good...Feel Better Launches Salon Awareness Campaign During National Breast Cancer Awareness Month
7. Charlotte Attorney Calls on North Carolina Senate to Pass "Comparative Negligence" Bill in Order to Better Protect Injury Victims in State
8. NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism: Fragile X
9. Orlando Regional Medical Center (ORMC) Implements PNA FISH(R) Tests to Help Provide Better Care for Patients with Bloodstream Infections
10. Can pen and paper help make electronic medical records better?
11. Look Good...Feel Better and OPI Celebrate 20 Years of Helping Women Cope With Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: